| Nov 13 |
OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ...
|
| Nov 13 |
OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript
|
| Nov 12 |
OncoCyte GAAP EPS of -$0.98 misses by $0.54, revenue of $0.11M misses by $0.06M
|
| Nov 12 |
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
OncoCyte Q3 Earnings Preview
|
| Nov 11 |
What to Expect from OncoCyte's Earnings
|
| Nov 6 |
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
|
| Oct 16 |
OncoCyte files for secondary stock offering
|
| Oct 16 |
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
|
